Skip to Main Content

Author Details

John M Louis
National Institute of Diabetes and Digestive and Kidney Diseases
1988
196
56
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36893281Structures of brain-derived 42-residue amyloid-β fibril polymorphs with unusual molecular conformations and intermolecular interactions.Proc Natl Acad Sci U S A2023
37957287Insights into the mechanism of SARS-CoV-2 main protease autocatalytic maturation from model precursors.Commun Biol2023
37271339Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors.J Biol Chem2023
35233052Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor.Commun Biol2022
35477935Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease.Nat Commun2022
35700771Real-time Exchange of the Lipid-bound Intermediate and Post-fusion States of the HIV-1 gp41 Ectodomain.J Mol Biol2022
36334779Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor.J Mol Biol2022
36114420Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain.Commun Biol2022
35877206Global Dynamics of a Protein on the Surface of Anisotropic Lipid Nanoparticles Derived from Relaxation-Based NMR Spectroscopy.J Phys Chem B2022
35278268Visualizing Proteins in Mammalian Cells by <sup>19</sup> F NMR Spectroscopy.Angew Chem Int Ed Engl2022
35169792Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease: room-temperature X-ray and neutron crystallography, binding thermodynamics, and antiviral activity.Res Sq2022
32916024Concentration-Dependent Structural Transition of the HIV-1 gp41 MPER Peptide into α-Helical Trimers.Angew Chem Int Ed Engl2021
33644875A weakened interface in the P182L variant of HSP27 associated with severe Charcot-Marie-Tooth neuropathy causes aberrant binding to interacting proteins.EMBO J2021
33932439MWC allosteric model explains unusual hemoglobin-oxygen binding curves from sickle cell drug binding.Biophys J2021
34705466Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease.J Med Chem2021
34375097Constraints on the Structure of Fibrils Formed by a Racemic Mixture of Amyloid-β Peptides from Solid-State NMR, Electron Microscopy, and Theory.J Am Chem Soc2021
34804549Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography.IUCrJ2021
34623907Transient lipid-bound states of spike protein heptad repeats provide insights into SARS-CoV-2 membrane fusion.Sci Adv2021
32558168Probing the Interaction between HIV-1 Protease and the Homodimeric p66/p66' Reverse Transcriptase Precursor by Double Electron-Electron Resonance EPR Spectroscopy.Chembiochem2020
32093836Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease.Methods Enzymol2020
32620782Fast three-color single-molecule FRET using statistical inference.Nat Commun2020
32341150Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.Proc Natl Acad Sci U S A2020
32478251Visualizing Tetrahedral Oxyanion Bound in HIV-1 Protease Using Neutrons: Implications for the Catalytic Mechanism and Drug Design.ACS Omega2020
32527859Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease.Proc Natl Acad Sci U S A2020
31042030Inhibition of HIV Maturation via Selective Unfolding and Cross-Linking of Gag Polyprotein by a Mercaptobenzamide Acetylator.J Am Chem Soc2019
31587829Diverse Folding Pathways of HIV-1 Protease Monomer on a Rugged Energy Landscape.Biophys J2019
29277995Tilted, Uninterrupted, Monomeric HIV-1 gp41 Transmembrane Helix from Residual Dipolar Couplings.J Am Chem Soc2018
30230835Three-Color Single-Molecule FRET and Fluorescence Lifetime Analysis of Fast Protein Folding.J Phys Chem B2018
30509980Probing the mechanism of inhibition of amyloid-β(1-42)-induced neurotoxicity by the chaperonin GroEL.Proc Natl Acad Sci U S A2018
29512300Co-Evolutionary Fitness Landscapes for Sequence Design.Angew Chem Int Ed Engl2018
28760960Oligomerization of the tetramerization domain of p53 probed by two- and three-color single-molecule FRET.Proc Natl Acad Sci U S A2017
28195728Room Temperature Neutron Crystallography of Drug Resistant HIV-1 Protease Uncovers Limitations of X-ray Structural Analysis at 100 K.J Med Chem2017
29087351Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR.Proc Natl Acad Sci U S A2017
26812046Analysis of Fluorescence Lifetime and Energy Transfer Efficiency in Single-Molecule Photon Trajectories of Fast-Folding Proteins.J Phys Chem B2016
27791180Transient HIV-1 Gag-protease interactions revealed by paramagnetic NMR suggest origins of compensatory drug resistance mutations.Proc Natl Acad Sci U S A2016
27992544Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics.PLoS One2016
27170547Evolution under Drug Pressure Remodels the Folding Free-Energy Landscape of Mature HIV-1 Protease.J Mol Biol2016
27513582Insights into the Conformation of the Membrane Proximal Regions Critical to the Trimerization of the HIV-1 gp41 Ectodomain Bound to Dodecyl Phosphocholine Micelles.PLoS One2016
27039930Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme.Biochemistry2016
26958828Long-Range Electrostatics-Induced Two-Proton Transfer Captured by Neutron Crystallography in an Enzyme Catalytic Site.Angew Chem Int Ed Engl2016
25470009Conformation of inhibitor-free HIV-1 protease derived from NMR spectroscopy in a weakly oriented solution.Chembiochem2015
26385843Pressure-induced structural transition of mature HIV-1 protease from a combined NMR/MD simulation approach.Proteins2015
26506247The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.Biochemistry2015
26266692Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease.Biochemistry2015
26336107Evidence of Distinct Channel Conformations and Substrate Binding Affinities for the Mitochondrial Outer Membrane Protein Translocase Pore Tom40.J Biol Chem2015
26182121Testing Landscape Theory for Biomolecular Processes with Single Molecule Fluorescence Spectroscopy.Phys Rev Lett2015
26010498Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20.J Med Chem2015
25631354Complete dissociation of the HIV-1 gp41 ectodomain and membrane proximal regions upon phospholipid binding.J Biomol NMR2015
25757985Dependence of distance distributions derived from double electron-electron resonance pulsed EPR spectroscopy on pulse-sequence time.Angew Chem Int Ed Engl2015
24550514Dissociation of the trimeric gp41 ectodomain at the lipid-water interface suggests an active role in HIV-1 Env-mediated membrane fusion.Proc Natl Acad Sci U S A2014
  • 1 - 50 of 196

Recommended Authors

Novartis Institute for Tropical Diseases
Career Start Year 2008
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 2
University of Massachusetts Chan Medical School
Career Start Year 2004
Number of shared co-authors 0
Stanford University
Career Start Year 2003
Number of shared co-authors 1
University of Washington
Career Start Year 2002
Number of shared co-authors 2
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 0
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year 1998
Number of shared co-authors 2
Pennsylvania State University College of Medicine
Career Start Year 1998
Number of shared co-authors 2
Robert Wood Johnson Medical School, The State University of New Jersey
Career Start Year 1997
Number of shared co-authors 2
University of Cambridge
Career Start Year 1996
Number of shared co-authors 4
Swiss Federal Institute of Technology
Career Start Year 1996
Number of shared co-authors 1
Weizmann Institute of Science
Career Start Year 1996
Number of shared co-authors 2
Nankai University
Career Start Year 1995
Number of shared co-authors 2
Monash University
Career Start Year 1994
Number of shared co-authors 1
The University of Manchester
Career Start Year 1991
Number of shared co-authors 4
University of Massachusetts Chan Medical School
Career Start Year 1990
Number of shared co-authors 1
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 3
Sanford-Burnham-Prebys Medical Discovery Institute
Career Start Year 1987
Number of shared co-authors 0
University of Oxford
Career Start Year 1986
Number of shared co-authors 2
Indian Institute of Science
Career Start Year 1985
Number of shared co-authors 1
Institute of Systems, The University of Liverpool
Career Start Year 1984
Number of shared co-authors 4
University of Utah School of Medicine
Career Start Year 1982
Number of shared co-authors 1
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1982
Number of shared co-authors 1
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1980
Number of shared co-authors 1
University of Oxford
Career Start Year 1976
Number of shared co-authors 3
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year 1975
Number of shared co-authors 2
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 1974
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 1974
Number of shared co-authors 2
Columbia University
Career Start Year 1968
Number of shared co-authors 2
University of California San Francisco
Career Start Year 1965
Number of shared co-authors 2

Collaborators

University of Pittsburgh
Co-authored papers 26
National Institutes of Health
Co-authored papers 22
University of Pittsburgh School of Medicine
Co-authored papers 18
CNRS, Universite de Strasbourg
Co-authored papers 5
Co-authored papers 4
Spanish National Cancer Research Centre (CNIO)
Co-authored papers 3
Co-authored papers 2
Albert Einstein College of Medicine
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Co-authored papers 1
Profectus BioSciences Inc.
Co-authored papers 1
National Institutes of Health
Co-authored papers 1
University of Southampton Highfield Southampton SO17 1BJ UK.
Co-authored papers 1
Center for AIDS Research, University of California San Diego
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 1
Co-authored papers 1
Medical University of South Carolina
Co-authored papers 1
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
University at Buffalo, State University of New York
Co-authored papers 1